Ginkgo Bioworks Holdings, Inc. Class A DNA 深 滬
等待開盤 03-26 09:30:00 美东时间
7.36
+0.190
+2.65%
華盛通- 最 高7.65
- 今 開7.30
- 成交量 104.67万股
- 最 低 7.2645
- 昨 收 7.17
- 總市值 4.56亿
- 52周最高 17.58
- 市盈率 靜 --
- 換手率 1.69%
- 52周最低 5.05
- 委 比 99.50%
- 總股本 6192.44万
- 歷史最高 634.56
- 量 比 0.94
- 振 幅 5.38%
- 歷史最低 5.00
- 每 手 1
- 風險率 2.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.
03-12 19:12
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinosaurs yet, but they are bringing extinct items back to life.
03-08 04:01
Ginkgo Bioworks Rolls Out Ginkgo Cloud Lab
Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo's autonomous lab infrastructure directly through a web
03-02 21:08
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork...
03-02 21:00
Ginkgo Bioworks To Spin Off Biosecurity Business To Investor Consortium In Exchange For A Minority Equity Position In The Business Alongside The Investors
Ginkgo today announced it has reached an agreement to sell the Company's biosecurity business to a consortium of investors ("Investors") in exchange for a minority equity position in the business alongside the Investors.
02-27 05:47
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share
02-27 05:33
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Ginkgo Bioworks Demonstrates, In Collaboration With OpenAI, An AI System That Autonomously Designed, Executed, And Learned From Biological Experiments With Minimal Human Involvement; Co. Reports The System Reduced Cell-Free Protein Synthesis Reaction Costs By 40% Relative To State Of The Art; GPT-5-Driven Autonomous Lab Executed Over 36,000 Experiments
Ginkgo Bioworks (NYSE:DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned from biological experiments with minimal human involvement. In
02-06 03:10
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
